#Poultry Diagnostics Market Industry | Explore Tumblr Posts and Blogs

animal-care · 2 months

Text

Exploring the Animal Health Market: Trends, Growth, and Key Players

Introduction to the Animal Health Market

The Animal Health Market encompasses a wide range of products and services aimed at promoting the well-being and welfare of animals, including livestock, pets, and companion animals. This market plays a crucial role in ensuring the health and productivity of animals across various sectors, including agriculture, veterinary medicine, and pet care.

Understanding Market Dynamics

The animal health market is driven by several factors, including:

Increasing Pet Ownership: Growing pet ownership rates worldwide have led to greater demand for veterinary services, pet care products, and pharmaceuticals to maintain the health and well-being of companion animals.

Rising Livestock Production: With global population growth and changing dietary preferences, there is a growing demand for meat, dairy, and other animal-derived products, driving the need for animal health products to maintain the health and productivity of livestock.

Prevalence of Animal Diseases: Infectious diseases, parasites, and other health issues pose significant threats to animal health and production. As a result, there is a continuous demand for vaccines, medications, and preventive treatments to control and manage these diseases.

Market Segments

The animal health market can be segmented into several key categories, including:

Pharmaceuticals: This segment includes veterinary drugs, medications, vaccines, and biological products used to treat and prevent various diseases and health conditions in animals.

Feed Additives: Feed additives such as probiotics, enzymes, vitamins, and minerals are used to enhance the nutritional value of animal feed, promote growth, and improve overall health.

Medical Devices: Veterinary medical devices, including diagnostic equipment, surgical instruments, and monitoring devices, play a vital role in diagnosing, treating, and managing animal health conditions.

Market Size and Growth

The global animal health market has experienced steady growth in recent years, driven by increasing investments in animal welfare, advancements in veterinary medicine, and the expansion of animal farming and pet care industries. According to market research reports, The global animal health market was valued at over USD 44 billion in 2021. It is projected to grow at a compound annual growth rate (CAGR) of approximately 5% from 2022 to 2027. The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, fueled by rising pet ownership and increasing demand for livestock products.

Key Players in the Animal Health Market

Several leading companies operate in the animal health market, offering a wide range of products and services. Some of the key players include:

Zoetis Inc.: As the world's largest animal health company, Zoetis offers a comprehensive portfolio of pharmaceuticals, vaccines, and diagnostics for livestock and companion animals.

Merck Animal Health: Merck Animal Health specializes in developing and manufacturing vaccines, pharmaceuticals, and health management solutions for livestock, poultry, and pets.

Boehringer Ingelheim Animal Health: Boehringer Ingelheim offers a broad range of animal health products, including vaccines, parasiticides, and pharmaceuticals for both companion animals and livestock.

Elanco Animal Health: Elanco Animal Health focuses on developing innovative solutions for animal health and well-being, including vaccines, parasiticides, and nutritional products for livestock and pets.

Emerging Trends in Animal Health

Telemedicine and Digital Health: The adoption of telemedicine and digital health technologies is revolutionizing veterinary care, allowing for remote consultations, diagnosis, and monitoring of animals' health and well-being.

Personalized Medicine: Advances in genetics and precision medicine are enabling personalized treatment and management plans tailored to individual animals' unique genetic makeup and health needs.

Focus on Preventive Healthcare: There is a growing emphasis on preventive healthcare in animal health, with pet owners and livestock producers increasingly investing in vaccinations, regular check-ups, and wellness programs to maintain optimal health and prevent diseases.

Conclusion

The Animal Health Market plays a vital role in ensuring the health, welfare, and productivity of animals worldwide. With increasing pet ownership, rising demand for livestock products, and advancements in veterinary medicine, the market is poised for continued growth and innovation. By addressing emerging trends, investing in research and development, and collaborating with key stakeholders, the animal health industry can contribute to a healthier and more sustainable future for animals and humans alike.

0 notes

industryforecastnews · 3 months

Text

Enzymes Market Size To Reach $20.31 Billion By 2030 | CAGR: 4.9%

Enzymes Market Growth & Trends

The global enzymes market size was estimated at USD 20.31 billion in 2030 and is expected to grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2030. The rising consumption of products on the account of the increasing awareness regarding an individual’s health is likely to positively influence the product demand over the forecast period.

Carbohydrase is bifurcated as cellulose, amylase, pectinase, xylanase, and lactase. It is widely used as an ingredient in the formulation of carbonated drinks. The growing usage of different kinds of carbohydrases in the animal feed and pharmaceutical industry is further projected to boost the overall industry demand in the coming years.

In North America, the U.S. is dominating the market for enzymes across the region on the account of the changing consumer preferences and rising demand for organic and nutritional food items from the food & beverage industry. Furthermore, the escalating market growth from the pharmaceutical and nutraceutical industry is anticipated to fuel the industry growth over the forecast period.

The market is an oligopolistic market with major players dominating the marketspace such as DSM, Novozymes, and DuPont Danisco among others. There is a significant rise in the demand for high-quality specialty enzymes across the globe. Thus, raw material distributors and manufacturers are witnessing a spike in lucrative opportunities to offer uniform and superior quality products via a systematic supply chain network.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/enzymes-industry

Enzymes Market Report Highlights

Food & Beverages segment accounted for more than 22.9% in 2022of the industrial type share due to the rising usage of enzymes in bakery and functional food products

Industrial emerged as the largest type segment in 2022 and is estimated to generate revenue of over USD 11.42 billion by 2030

Microorganisms emerged as the largest source segment in 2022 and are estimated to generate revenue over USD 17.47 billion by 2030

North America is projected to witness the fastest growth rate of 6.6% from 2023 to 2030 due to the rising R&D activities across the developed countries coupled with the presence of numerous end-use application manufacturers in the pharmaceuticals, food & beverage, and personal care & cosmetics sector

Pharmaceutical emerged as the largest specialty type segment with a revenue share of 40.6% in 2022, due to the increasing usage of the product in different applications including wound healing, diagnosing diseases, and killing disease-causing bacteria

Enzymes Market Segmentation

Grand View Research has segmented the global enzymes market report based on type, product, source, and region

Enzymes Type Outlook (Revenue, USD Million, 2018 - 2030)

Industrial Enzymes

Food & Beverages

Meat Processing

Dairy Products

Beverages

Bakery & Confectionery

Other Food Products

Detergents

Animal Feed

Ruminants

Swine

Poultry

Aquafeed

Others

Biofuels

Textiles

Pulp & Paper

Nutraceutical

Personal Care & Cosmetics

Wastewater

Others

Specialty Enzymes

Pharmaceutical

Research & Biotechnology

Diagnostics

Biocatalyst

Enzymes Product Outlook (Revenue, USD Million, 2018 - 2030)

Carbohydrase

Proteases

Lipases

Polymerases & nucleases

Others

Enzymes Source Outlook (Revenue, USD Million, 2018 - 2030)

Plants

Animals

Microorganisms

Enzymes Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

Germany

France

Spain

Italy

Asia Pacific

China

India

Japan

South Korea

Indonesia

Australia

Central & South America

Brazil

Argentina

Middle East & Africa

Saudi Arabia

Turkey

List of Key Players in the Enzymes Market

BASF

Novozymes

DuPont Danisco

DSM

NOVUS International

Associated British Foods Plc

Chr. Hansen Holding A/S

Advanced Enzyme Technologies

Lesaffre

Adisseo

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/enzymes-industry

#Enzymes Market #Enzymes Market Size #Enzymes Market Trends #Enzymes Market Forecast

0 notes

prabhatjairam · 3 months

Text

Business opportunities in rural areas

There is no doubt that India is home to thousands of villages and impoverished regions. A sizable portion of the population still lives in rural India and works in small-scale industries in the local villages. This portion is a sizable contributor to India's GDP and is sometimes referred to as the country's economic engine. So, using a variety of small business concepts for rural areas can help more than 70% of Indians who live there.

If you want to open a business in a rural location, there is no need to move to a big metropolis because starting a small business in a village can give you an equal opportunity to make money and get a good return on your investment. We will discuss some of the top business concepts with rapid growth rates in this blog post.

Fertilizer business

Starting a fertilizer and pesticide business makes excellent economic sense because agriculture accounts for a big portion of the rural Indian economy. In addition to giving plants nourishment, fertilizers increase the yield of many crops, including maize, wheat, and rice. You must apply for and receive the necessary licenses and permits from the local government to launch this firm. To help your business expand, you can also sell seeds in addition to fertilizer and pesticides.

Poultry farm business

The poultry farm industry is the most profitable small business with the potential for small communities that require little capital, land, and labor. Culturing poultry and cattle is indeed the best business to start in a rural region where you can grow it gradually.

Numerous lenders are assisting people in establishing livestock and poultry farming enterprises by providing small business loans. However, opportunities are endless on the demand side, in both urban and rural locations, which will increase your profits in your business.

Diagnostic Center

Another fantastic option for rural people is to establish a diagnostic center in their communities so that people do not have to rush here and there. With the help of health care centers, people can regularly conduct health examinations, which can aid them in maintaining a nice and healthy lifestyle. Moreover, opening a diagnostic center can be a manageable financial commitment. The initial investment covers the rent for the facility, the cost of the medications, the staff's salaries, and a current certification.

Flour mill business

A flour mill business is also a suitable choice as flour is consumed by each individual. If you start this business, then rural residents don't need to purchase pricey packaged flour from large corporations. Nonetheless, India's flour mill sector is highly profitable and has tremendous growth potential. According to estimates, the Indian flour mill market is valued at Rs. 15,000 crores and expanding at a CAGR of 5%. It is undeniably a basic human need that aids in their development. A single flour mill can also sell the finished goods to other villages to increase its earnings.

Related Daily Booster Article| study24hr.com

Dairy business

All of us know that milk is a basic necessity that households require daily. In our nation's villages and rural areas, milk is widely available. It is one of the most profitable business ventures you may launch. You can start a dairy business by buying milk from villagers and selling it to businesses in cities. A lender can offer cheaper lending rates and customizable repayment terms on loans for the initial money needed. This village-based small business has the potential to be very successful in the long run.

Electronics store

Because rural people are a part of this digital era, they are aware of the most recent scientific discoveries, technological advancements, and innovations. Many rural communities use modern devices on par with city dwellers. Since mobile phones have become a basic requirement in this modern era, opening an electronics store in a small town is a great idea. However, the vast majority of people in India are village dwellers, and practically all of them desire to speak with their families. The Mobile Shop enterprise is thus among the top small business concepts to launch in rural locations.

To get educational help from the top online educational portal, kindly connect with "study24hr.com." It is a remarkable platform where learners and teachers can connect and interact in an effective learning environment. The primary goal of the website is to improve students' academic performance and understanding

In light of this, "study24hr.com" provides its learners with access to various study materials such as mock test papers, daily boosters, academic notes, tutorial videos, and many more. Furthermore, teachers and educational institutes are permitted to post their course structures on their websites to solicit feedback from prospective students.

Chemist store

Opening a medical supply store is another business opportunity for people living in rural areas. Typically, individuals travel great distances to adjacent cities to purchase the precise medications that their doctors have advised. So, it will be advantageous for you and the residents if you open a pharmacy in the village itself. You can make a nice living by providing all available medications for blood pressure, diabetes, insulin, and other conditions. Also, you can order drugs from your supplier on a just-in-time (JIT) basis if there isn't a high enough demand for them.

Conclusion

These were a few creative small company concepts for Indian small towns. We hope you learned something about each of them. If starting your own business has always been your ambition, now is the time to make it a reality. Remember, if the circumstances are favorable, starting a small business in an Indian hamlet or rural area can be lucrative.

Make sure you put a lot of effort into accomplishing your objectives, whether you create a mobile shop or a medical store. Set your mind to it and strive to achieve it. It doesn't matter if you don't get it right away because nobody succeeds on their first try. Always keep in mind that failing isn't about giving up; it's about losing your position. So, never give up on your dreams because only you can make them come true. Hence, start your journey today!

#rural life #business opportunities #rural areas #poverty #villages #India #business #livelihood #education #fertilizer business #investment

0 notes

researchinsights24 · 3 months

Text

Amino Acid Market Propelled by Rising Demand for Nutraceuticals

The global amino acid market plays a vital role in various industrial applications due to its essential role in protein synthesis and metabolism. Amino acids are organic compounds that are naturally occurring in the human body and are the building blocks of proteins. They are constituent of all living cells and are used to produce hormones, antibodies and cellular components. There are twenty standard amino acids, out of which nine are essential amino acids that cannot be produced in the body and must be consumed through sources of protein. The amino acids are used in pharmaceuticals, cosmetics, nutraceuticals, food industry among others. The Global Amino Acid Market Size is estimated to be valued at US$ 27.4 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The global amino acid market is witnessing a high growth owing to increase in demand for nutraceuticals and functional food products. Amino acid supplements are extensively used in the treatment of various lifestyle and chronic diseases like obesity, diabetes, depression, and stress among others. Nutraceuticals containing amino acids like lysine, tryptophan, and leucine are gaining popularity for their role in improving immunity, brain health, mood and metabolism. The growing health conscious consumer base and inclination towards preventive healthcare is driving the adoption of amino acid fortified foods and beverages globally. Additionally, expansion offood and feed industries especially in Asia Pacific due to rising disposable income levels is boosting the consumption of amino acids which are extensively used as feed additives to enhance the nutrition content of livestock and poultry feed. Rapid urbanization, growing vegan population and rising demand for alternative protein sources is further propelling the sales of plant-based proteins which contain high amounts of essential amino acids. SWOT Analysis Strength: The amino acid market is highly fragmented with the presence of many domestic players. This fragmented market poses difficulties for new players to enter and dominate the market. The market is experiencing high demand for essential amino acids from industries like food and feed,personal care and cosmetics,pharmaceutical which is propelling the market growth. R&D in novel drug delivery using amino acids will drive innovation in therapeutics. Weakness: Regulatory barriers for approval of new drugs based on amino acids are quite stringent. Clinical trials and approval process increases costs and timelines for new product development. Storage and short shelf life of some amino acids makes distribution challenging. Opportunity: Increasing cases of malnutrition, especially in developing countries presents an opportunity. Rising health-conscious population is fueling demand for dietary supplements containing amino acids. Personalization of medicine using biomarkers can boost diagnostics and testing volumes. Threats: Price volatility of raw materials can impact production costs. Substitutes available for some non-essential amino acids pose competition. Stringent environmental regulations around amino acid production industries increase compliance costs. Dependence on China and India for raw material supply exposes to supply chain disruptions. Key Takeaways The global amino acid market is expected to witness high growth over the forecast period owing to factors such as increasing demand from feed, pharmaceutical and food industries. The market holds a promising growth potential in the diagnostic sector for development of precision therapeutics.

Regional analysis: North America dominates currently with a share of over 35% due to developed healthcare infrastructure and growing aging population driving diagnostic volumes. Asia Pacific is expected to grow at fastest CAGR during 2023-2030 on back of expanding consumer goods industry,rising health awareness and increasing contract manufacturing in countries like India and China. Key players: Key players operating in the amino acid market are Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMÃ©rieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics, Inc., Bristol-Myers Squibb Company, and Foundation Medicine, Inc.

Get More Insights Here: https://www.newsstatix.com/amino-acid-market-size-share-and-growth-forecast-2023-2030/

0 notes

harshalj79 · 3 months

Text

Asia-Pacific Livestock Diagnostics Market by Product (Consumables {Swine Fever, Influenza}, System, Software), Technology (Immunodiagnostics {ELISA, LFA}, PCR), Animal Type (Swine, Bovine, Poultry), End User (POC, Veterinary Hospital) - Forecast to 2030

#Asia-Pacific Livestock Diagnostics Market #Livestock Diagnostics Market #Livestock Diagnostics #veterinary #veterinary diagnostics #animals #animal health #medical devices #healthcare

0 notes

market-spy · 4 months

Text

Global Veterinary Infectious Disease Diagnostics Market Size, Growth, Forecast: Zooming in on Animal Health

The global veterinary infectious disease diagnostics market is booming, projected to balloon from $1.8 billion in 2021 to a whopping $3.88 billion by 2030, a healthy CAGR of 8.9%. This surge reflects a growing focus on animal health as well as technological advancements offering faster, more accurate diagnoses. Let's delve deeper into this exciting market.

Key Drivers Boosting Market Growth:

Rising Concern for Animal Health: Increased awareness about animal well-being and zoonotic diseases fuels investments in preventive measures and early disease detection.

Prevalence of Infectious Diseases: Factors like globalization, climate change, and evolving pathogens contribute to the spread of infectious diseases in animals, necessitating robust diagnostic tools.

Technological Advancements: Cutting-edge diagnostics like point-of-care testing and molecular assays provide rapid, precise results, enabling swift treatment decisions.

Growing Pet Ownership: The surge in pet ownership, particularly in developed countries, drives demand for advanced veterinary care and diagnostics.

Market Segmentation: Two Main Players:

Food-producing animals: This dominant segment, encompassing livestock and poultry, faces the burden of ensuring food safety and preventing animal-borne diseases.

Companion animals: The rapid growth of this segment is fueled by rising pet ownership and increased spending on their health.

Beyond the Segments: End-use Matters:

Veterinary hospitals: These primary care facilities remain the largest users of diagnostic tools, catering to a diverse range of animals.

Reference laboratories: Offering specialized expertise and advanced technologies, these labs are increasingly sought for complex testing needs.

In-house/point-of-care laboratories: Portable and user-friendly POCT devices are gaining traction for on-site,rapid diagnoses in clinics.

Regional Variations:

North America: Currently dominates the market due to a developed veterinary infrastructure and high awareness of animal health.

Asia Pacific: This region boasts the fastest growth potential, fueled by a rising middle class, increasing pet ownership, and government initiatives to improve animal healthcare.

Challenges to Overcome:

High Cost of Advanced Diagnostics: Access to cutting-edge technologies might be limited for smaller clinics or resource-constrained regions.

Limited Awareness and Access in Developing Regions: Infrastructure gaps and lack of trained personnel can hinder market penetration in certain areas.

Market Trends Shaping the Future:

Point-of-care testing: POCT devices will continue to revolutionize diagnostics with their rapid results and convenience.

Digitalization and Telemedicine: Remote consultations and online diagnostic tools will bring efficiency and expand access to veterinary care.

Personalized Medicine: Tailored treatment plans based on individual animal needs are gaining traction,requiring advanced diagnostics. For more information: https://www.skyquestt.com/report/veterinary-infectious-disease-diagnostics-market

The Takeaway:

The global veterinary infectious disease diagnostics market is brimming with promising opportunities for manufacturers, innovators, and service providers. By addressing challenges, embracing technological advancements, and catering to regional needs, this market can significantly contribute to improved animal health and well-being worldwide.

Additional Insights:

This report offers a comprehensive overview of the market, including detailed segment analysis, regional insights, key trends, and challenges.

It provides valuable information for stakeholders in the veterinary industry, including animal health companies,diagnostic labs, and veterinary professionals.

The report also identifies potential growth areas and investment opportunities in this ever-evolving market.

About Us:

SkyQuest Technology Group is a Global Market Intelligence, Innovation Management & Commercialization organization that connects innovation to new markets, networks & collaborators for achieving Sustainable Development Goals.

SkyQuest Technology Consulting Pvt. Ltd.

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 617–230–0741

Email- [email protected]

Website: https://www.skyquestt.com

0 notes

pharmanucleus1 · 4 months

Text

Anti-Coccidial Drugs Market : Unlocking Opportunities with Gorwth Insights and Advancements

Anticoccidial Drugs Market Insights

In April 2019, Creative Diagnostics developed anticoccidial drug assay products to test anticoccidial drug residues in animals. This advancement and awareness of anticoccidial drugs will impact the trend of the anticoccidial drugs market. Growing awareness of animal health and zootonic diseases is expected to increase acceptance of anticoccidial drugs. The rising carnivorous population and reliance on bovine products is expected to be a driving factor for the growth of the anticoccidial drugs market. Additionally, the increase in research and development of veterinary drugs is expected to provide growth opportunities for anticoccidial drugs.

Click here for full report:

The growth of the global anticoccidial drugs market is expected to be driven by increasing outbreaks of coccidia combined with growing reliance on poultry products. Additionally, stringent government regulations aimed at maintaining livestock health in developed countries are expected to increase the adoption of anticoccidial drugs. Growing expenditure and pet owners' awareness of animal health is expected to be a driving force for the anticoccidial drugs market.

Conversely, certain government policies restricting the use of anticoccidial antimicrobial drugs in livestock are expected to inhibit the growth of the anticoccidial drugs market. Additionally, the growing demand for antibiotic-free meat has likely impacted the growing trend of the anticoccidial drugs market.

Anticoccidial Drugs Market Segment Analysis

By Drug Type

Ionophore Anticoccidials

Chemical Derivative Anticoccidials

Click here fore free sample request:

By Animal Type

Poultry

Swine

Cattle

Others

Competitive Key Players

Bayer Animal Healthcare

Boehringer Ingelheim

Ceva Animal Health Inc.

Elanco Animal Health (a subsidiary of Eli Lilly)

Merck

Merial

Virbac

Zoetis Animal Healthcare

Vetoquinol SA

Click here for full report:

Anticoccidial Drugs Market Geographical Analysis

The global anticoccidial drugs market has been segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. Developed countries in North America and Europe are estimated to dominate the global anticoccidiosis drug market due to established veterinary care and active government involvement in farm animal health and management. Asia-Pacific and Latin America countries are expected to register higher CAGR in the global anticoccal drugs market growth due to growing dependence on farm animals and an increasing number of pet owners of the company. In the Middle East and Africa, the unmet need for animal health is expected to be a driver of the anticoccal drugs market in the region.

Anticoccidial Drugs Market Key Developments

In 2014, Zoetis announced the reintroduction of Zoamix, a synthetic anticoccidial drug indicated for poultry.

In February 2015, Zoetis announced the completion of its acquisition of Abbott's animal health business.

In May 2016, Laboratorios Hipra received European Union approval for the company's coccidiosis vaccine Evalon

#Anti-Coccidial Drugs #Market Research #Industry Advancement #Coccidiosis Treatment #Pharmaceutical Innovations #Disease Prevention #Poultry Health #Livestock Farming #Drug Development #Market Trends

0 notes

techninja · 5 months

Text

Gumboro Disease Market: Trends, Challenges, and Future Prospects

Introduction:

Gumboro Disease, also known as Infectious Bursal Disease (IBD), is a highly contagious viral infection affecting poultry, particularly chickens. The disease primarily targets the immune system, specifically the Bursa of Fabricius, leading to immunosuppression and increased susceptibility to secondary infections. The economic impact of Gumboro Disease on the poultry industry is significant, making it a critical focus for research, diagnostics, and vaccine development. This article explores the current trends, challenges, and future prospects in the Gumboro Disease market.

Current Market Scenario:

The Gumboro Disease market has witnessed substantial growth in recent years, driven by the increasing global demand for poultry products. As the poultry industry expands to meet the growing protein needs of a rising population, the threat of Gumboro Disease becomes more pronounced. The market has responded with innovations in diagnostics, vaccines, and treatment strategies to manage and control the spread of the virus.

Diagnostic Advancements:

Early and accurate diagnosis is crucial for effective Gumboro Disease management. The market has seen advancements in diagnostic tools, including molecular techniques like polymerase chain reaction (PCR) and serological tests. These technologies enable quick and precise identification of the virus, allowing for prompt intervention and control measures.

Vaccine Development:

Vaccination remains a cornerstone in Gumboro Disease control. The market has witnessed the development of more sophisticated and effective vaccines, including live attenuated and inactivated vaccines. Continuous research focuses on enhancing vaccine efficacy, duration of immunity, and minimizing potential side effects. Novel vaccine delivery systems and adjuvants are also being explored to improve the overall performance of Gumboro Disease vaccines.

Challenges in Gumboro Disease Management:

Despite advancements, the Gumboro Disease market faces several challenges. One significant challenge is the constant evolution of the virus, leading to the emergence of new strains. This necessitates ongoing research to adapt existing vaccines and develop new ones to address emerging threats. Additionally, biosecurity measures and effective farm management practices play a pivotal role in preventing and controlling Gumboro Disease outbreaks, posing a challenge in regions with varying levels of infrastructure and awareness.

Globalization and International Trade:

The interconnectedness of the global poultry industry poses challenges in controlling the spread of Gumboro Disease. International trade in poultry products increases the risk of disease transmission across borders. Strict biosecurity measures, harmonized regulations, and international cooperation are essential to mitigate these challenges and ensure the sustainable growth of the poultry industry.

Future Prospects:

The future of the Gumboro Disease market holds promise with ongoing research and technological advancements. Emerging technologies, such as gene editing and recombinant DNA techniques, offer new avenues for developing next-generation vaccines with improved efficacy and safety profiles. Collaborations between academia, research institutions, and industry players are essential to drive innovation and address the evolving challenges posed by Gumboro Disease.

Conclusion:

The Gumboro Disease market is at the forefront of addressing critical issues in the poultry industry. While advancements in diagnostics and vaccines have improved disease management, challenges such as virus evolution and international trade complexities persist. The ongoing commitment to research, development, and international collaboration will be instrumental in shaping the future landscape of the Gumboro Disease market and ensuring the sustained health and growth of the global poultry industry.

0 notes

datadiscoveriesdaily · 5 months

Text

Veterinary Artificial Insemination Key Players, Growth, Analysis, by 2030

The Veterinary Artificial Insemination (AI) Market has emerged as a critical component of modern animal husbandry, revolutionizing the breeding practices in the veterinary industry. Artificial insemination involves the deliberate introduction of sperm into the reproductive tract of a female animal, bypassing natural mating. This method has gained widespread acceptance due to its efficiency in enhancing breeding outcomes, genetic improvement, and disease control in various animal species.

Click Here for In-Depth Insights: Download the Sample Report @ https://www.sanglobalresearch.com/request-sample/3044

The market's growth is propelled by several factors, with one of the key drivers being the increasing demand for improved genetics in livestock. Farmers and breeders are recognizing the benefits of AI in selectively breeding animals with desirable traits, such as enhanced milk or meat production, disease resistance, and overall better health. This demand for superior genetic material is fostering the adoption of artificial insemination techniques across diverse animal species, ranging from cattle and pigs to poultry and exotic species.

Furthermore, the growing awareness of the economic advantages associated with AI is stimulating market growth. Artificial insemination allows for the utilization of genetically superior sires, enabling farmers to optimize their breeding programs and enhance the overall productivity of their livestock. Additionally, AI contributes to the prevention of diseases that can be transmitted through natural mating, thereby improving the health of the animal population.

While the Veterinary AI market exhibits promising growth, it is not without challenges. One notable restraint is the high initial cost of implementing AI technologies. The equipment and expertise required for successful artificial insemination can be a significant financial investment for small-scale farmers. This economic barrier can limit the widespread adoption of AI, particularly in regions with limited resources. However, as technology advances and becomes more accessible, the cost associated with AI may decrease, potentially mitigating this challenge over time.

Government organizations play a pivotal role in shaping the landscape of the Veterinary AI market. Statistics from these entities highlight the significance of AI in animal breeding and its impact on the agriculture sector. According to recent data from the Department of Agriculture, the adoption of AI in livestock breeding has increased by 25% over the past five years. This growth underscores the government's recognition of the positive outcomes associated with artificial insemination, including improved animal health, increased food production, and enhanced agricultural sustainability.

The growth of the Veterinary AI market is also influenced by factors such as technological advancements in reproductive technologies, research and development initiatives, and the rising demand for animal by-products. As the global population continues to increase, there is a heightened focus on sustainable and efficient methods of food production. Artificial insemination aligns with this goal by facilitating the controlled breeding of livestock, contributing to the overall efficiency and productivity of the agriculture sector.

Inquire More and Share Questions If Any Before the Purchase on This Report at@ https://www.sanglobalresearch.com/customization/3044

Global Artificial Intelligence in Construction Market, Report Segmentation

Diagnostic Imaging Services Market, By Solution

Equipment & Consumables

Semen

Services

Diagnostic Imaging Services Market, By Type

Bovine

Swine

Diagnostic Imaging Services Market, By Distribution

Private

Public

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

About Us:

At San Global Research Report, we pride ourselves on our commitment to quality and accuracy. Our team of experienced researchers utilizes a combination of quantitative and qualitative methods to ensure that our findings are both accurate and reliable. With a strong emphasis on responsiveness, transparency, and collaboration, we work closely with our clients to understand their objectives and deliver actionable insights. Learn more about our research approach and how it can benefit your business.

Address: Gera Imperium Rise, Phase 2 Hinjewadi, Pune, India

San Global Research | Web: http://www.sanglobalresearch.com

Direct Line: +91 9209275355

E-mail: [email protected]

#Veterinary Artificial Insemination Market

0 notes

misdrnet · 6 months

Text

The brand is booming | Fight against swine fever, bird flu… This company practices "being an animal health expert and serving human health" with high-quality products! Zhaoqing High-tech Release 2023-10-07 20:12 Published in Guangdong

Opening language

Brand is an important carrier of the market value of enterprise products, and strengthening brand building is an important way to meet people's needs for a better life. In recent years, Zhaoqing High-tech Zone has made positive progress in brand building, its brand influence has steadily increased, and its role in promoting and leading the upgrading of the supply and demand structure has been significantly enhanced. Zhaoqing High-tech Publishing Co., Ltd. now launches the "Brand Dawang" column to show the Dawang brand story and strive to create a new situation of high-quality development.

Bird flu, African swine fever…

In recent years, major epidemics of livestock and poultry have occurred from time to time.

Veterinary vaccines are increasingly valued by domestic and foreign markets.

Located in Zhaoqing High-tech Zone

Zhaoqing Dahuanong Biopharmaceutical Co., Ltd.

(hereinafter referred to as "Da Huanong"),

In the battle against animal epidemics,

Using its own scientific research strength and process technology,

Protect the breeding industry,

Received support from domestic and foreign customers and experts

unanimously praised and trusted.

In 2004, it obtained the production qualification for highly pathogenic avian influenza inactivated vaccine; in 2018, it successfully developed a diagnostic test kit for African swine fever; in 2019, it jointly established the Huanong (Zhaoqing) Bioindustry Technology Research Institute with universities and the government… As a high-tech enterprise integrating research and development, production, sales and technical services of veterinary biological products, Huanong is the first listed enterprise in the veterinary pharmaceutical industry in Guangdong Province and is also the highly pathogenic avian influenza inactivated vaccine designated by the Ministry of Agriculture and Rural Affairs. A designated production enterprise that has been deeply involved in the field of animal disease prevention and control for 20 years, just to practice - "Be an animal health expert and serve human health."

Two animal epidemic prevention "epidemic" battles launched the brand

picture

"Dahuanong is the first built to comply with bird flu

Private enterprise in vaccine production GMP workshop. "

Zhan Xuanzi, deputy general manager of Dahuanong Company, recalled,

In the early days of its establishment, Dahuanong combined national policies and

Persist in strengthening technical cooperation with scientific research institutions and universities,

Continuously improve and innovate production processes,

grew rapidly.

And the two animal disease prevention "epidemic" battles,

Let Da Huanong become famous in one battle.

picture

Zhaoqing Dahuanong staff are conducting experiments. Photo by Wang Zhenyu

In 2004, the avian influenza epidemic was raging.

The Ministry of Agriculture at that time designated Dahuanong as

Designated manufacturer of highly pathogenic avian influenza vaccine,

Dahuanong’s scientific research team has a high sense of responsibility,

We worked overtime to provide nearly 6 billion doses of high-quality avian influenza vaccines.

to bring the epidemic under rapid control.

Wen's Group, the largest broiler breeding base in the country at that time

There are 80 million chickens in stock, relying on vaccination and vaccination.

It was a miracle that not a single case of bird flu occurred.

picture

Zhaoqing Dahuanong Experimental Animal Center.

Another "battle" took place in the summer of 2006.

At that time, blue-ear disease swept the country and the pig industry suffered a heavy setback.

Da Huanong once again faced danger and was ordered to do so.

Responsible for the development and production of vaccines.

It only took 80 days to complete the vaccine production

The entire process from the introduction of seeds to the delivery of finished products,

80 million doses of high-quality PRRS vaccine

Supplied vaccines for 15 provinces,

It has saved a lot of losses for my country's pig industry.

Strong R&D strength creates brand

picture

Over the years, Dahuanong has been insisting on

Driven by scientific research and innovation,

Continuously improve core competitiveness,

6% of revenue is invested in R&D every year.

A high proportion of R&D investment,

It has formed industry-leading R&D and innovation capabilities,

A number of poultry multi-conjugate vaccines have been launched,

From the original one shot to prevent one disease,

Now one shot can prevent multiple diseases.

picture

Dahuanong staff are conducting testing.

In 2018, in order to solve the problem of African swine fever,

Dahuanong successfully developed African swine fever antigen detection kit

and African swine fever antibody reagent detection kit,

It provides great help for disease detection in the pig industry.

“In the absence of a vaccine for African swine fever,

That is to use detection as a means of prevention and control.

Antigen detection kit, antibody reagent detection kit

It is widely used in major breeding enterprises across the country. "

said Ouyang Zhengliang, senior R&D researcher at Dahuanong.

It is reported that from 2018 to 2022, Dahuanong's new product revenue totaled 2.616 billion; in 2022, it not only won the Guangdong Provincial Government Quality Award Nomination Award, but was also successfully selected as a Guangdong Specialized and Special New Enterprise. At the same time, the "Dahuanong" brand was recognized by the national industry association Named as one of the "Top 10 Enterprises in the Veterinary Biological Products Category", Dahuanong has gradually achieved a double harvest of business performance and brand effect.

picture

Zhaoqing Dahuanong has developed the world's first live grass carp hemorrhagic disease vaccine.

Brand building

It is inseparable from the establishment of a team of high-quality scientific research talents.

Dahuanong adopts "salary + innovation rewards + equity incentives"

As well as a series of talent initiatives in Zhaoqing City and High-tech Zone,

Ensure that talents are “attracted, retained and put to use”,

Stimulate innovation vitality.

At present, Dahuanong has an innovation team of more than 200 people led by academicians and professors. Relying on the innovative vitality of talents, Dahuanong has so far obtained 50 registered new veterinary drugs, including 4 in Category I, and obtained more than 200 authorized patents. , won more than 20 provincial and national science and technology progress awards, and the achievement conversion rate reached 85%.

picture

Zhaoqing Dahuanong Quality Management Department was rated as "National March 8th Red Flag Collective".

In order to further stimulate employees’ innovation efforts,

Dahuanong and its employees jointly funded and established a

A partnership company named "Zhichuang Technology Center",

By purchasing intellectual property,

The company and its employees jointly fund the development of new products.

At present, the center has invested 4 million yuan in research and development of

A poultry product vaccine is expected to be launched on the market early next year.

It will bring an increase of more than 20 million yuan to the company.

High-quality products establish the brand

picture

All along,

Dahuanong provides customers with epidemic prevention products,

From raw material procurement, production, testing to sales

High standards of management are adhered to in all aspects.

According to the five elements of "people, machine, material, method and environment"

Provide comprehensive production support.

picture

Zhaoqing Dahuanong Laboratory.

Dahuanong also has first-class

Animal disease detection equipment and functional laboratories,

A diagnostic reagent workshop has been built to provide customers with

Full service of animal disease prevention and control technology.

Currently, Dahuanong has four

A production base with internationally advanced technology,

9.4 billion doses of poultry vaccines are supplied every year.

200 million doses of vaccine for pigs.

Product application covers the whole country,

Exported to Egypt, Indonesia, Vietnam and other countries and regions,

Rated as “One Belt, One Road”

One of the top 100 agricultural products export enterprises in China.

picture

Zhaoqing Dahuanong staff are conducting testing. Photo by Wang Zhenyu

A new journey, start again.

Zhan Xuanzi said that in order to maintain the "Da Huanong" brand,

To further meet market demand,

Dahuanong proposed new strategic goals this year.

Fight with all your strength for "345":

That is to say, we will make every effort to maintain growth, maintain inheritance, and seek listing;

Through cost-driven, market-driven,

Innovation initiatives such as innovation drive and culture drive,

Strive to be independently listed within five years and achieve a new leap forward

品牌大旺 | 战猪瘟、抗禽流感……这家企业以优质产品践行“做动物保健专家，为人类健康服务”！肇庆高新发布 2023-10-07 20:12 发表于广东

开栏语

品牌是企业产品市场价值的重要载体，加强品牌建设是满足人民美好生活需要的重要途径。近年来，肇庆高新区品牌建设取得积极进展，品牌影响力稳步提升，对供需结构升级的推动引领作用显著增强。肇庆高新发布现推出《品牌大旺》专栏，展现大旺品牌故事，努力开创高质量发展新局面。

禽流感、非洲猪瘟……

近年来，家畜家禽重大疫情时有发生，

兽用疫苗越来越受到国内外市场重视。

坐落于肇庆高新区的

肇庆大华农生物药品有限公司

（下称“大华农”），

在动物疫病防治战“疫”中，

用自身的科研实力与工艺技术，

为养殖业保驾护航，

得到了国内外客户、专家的

一致好评和信赖。

2004年，获得高致病性禽流感灭活疫苗生产资质；2018年，成功研制非洲猪瘟诊断检测试剂盒；2019年，与高校和政府共建华农（肇庆）生物产业技术研究院……大华农作为一家集兽用生物制品研发、生产、销售和技术服务为一体的高新技术企业，是广东省兽药药业第一家上市企业，也是农业农村部指定的高致病性禽流感灭活疫苗定点生产企业，深耕动物疫病防控领域二十载，只为践行——“做动物保健专家，为人类健康服务”。

两场动物疫病防“疫”战打响品牌

图片

“大华农是第一个建成符合禽流感

疫苗生产GMP车间的民营企业。”

大华农公司副总经理詹烜子回忆道，

在成立初期，大华农结合国家政策，

坚持跟科研机构、高校加强技术合作，

不断完善、创新生产工艺，

迅速成长起来。

而两场动物疫病防“疫”战，

让大华农一战成名。

图片

肇庆大华农工作人员正在进行实验。王振宇摄

2004年，禽流感疫情肆虐，

当时的农业部指定大华农为

高致病性禽流感疫苗的定点生产企业，

大华农的科研团队以高度的责任感，

加班加点提供了优质禽流感疫苗近60亿羽份，

使疫情得到迅速控制。

当时全国最大的肉鸡养殖基地温氏集团

存栏8000万只鸡，依靠疫苗免疫接种，

创造了没有发生一例禽流感的奇迹。

图片

肇庆大华农实验动物中心。

另一场“战役”是在2006年入夏，

当时猪蓝耳病席卷全国，养猪业遭受重挫。

大华农再次临危受命，

负责疫苗的研制和生产。

仅用了80天的时间，就完成了疫苗生产

从种毒引进到成品出厂的全部工序，

8000万头份优质的蓝耳病疫苗

供应了15个省份的防疫用苗，

为我国养猪业挽救了一大笔损失。

雄厚研发实力成就品牌

图片

多年来，大华农一直坚持

以科研创新为驱动，

不断提升核心竞争力，

每年拿出营收的6%用于研发投入，

高比例的研发投入，

形成了行业较领先的研发创新能力，

推出了多个禽用多联疫苗，

由原来的一针防疫一个病种，

到现在一针可防多个病种。

图片

大华农工作人员正在进行检测工作。

2018年，为解决非洲猪瘟疫情问题，

大华农成功研制出非洲猪瘟抗原检测试剂盒

和非洲猪瘟抗体试剂检测试剂盒，

为养猪行业疫病检测提供了极大帮助。

“在没有非洲猪瘟疫苗的情况下，

就是以检测为防控手段，

抗原检测试剂盒、抗体试剂检测试剂盒

在全国各大养殖企业广泛地使用。”

大华农高级研发员欧阳征亮说。

据悉，2018年至2022年，大华农新产品收入合计26.16亿；2022年不仅获得了广东省政府质量奖提名奖，而且顺利入选广东专精特新企业，同时“大华农”品牌被国家行业协会评为“兽用生物制品类10强企业”，大华农逐步实现了经营业绩与品牌效应的双丰收。

图片

肇庆大华农研发出世界首个草鱼出血病活疫苗。

品牌的打造

离不开高素质科研人才团队的搭建。

大华农通过“薪酬+创新奖励+股权激励”

以及肇庆市和高新区的一系列人才举措，

确保人才“引得来、留得住、用得上”，

激发创新活力。

目前，大华农拥有以院士、教授为带头人的创新团队200多人，依托人才的创新活力，截至目前，大华农企业获得注册新兽药50项，其中一类4项，获得授权专利200多件，获得省级国家级科技进步奖20多项，成果转化率达85%。

图片

肇庆大华农质量管理部被评为“全国三八红旗集体”。

为进一步激励员工的创新力度，

大华农与员工共同出资成立了一间

名为“智创科技中心”的合伙人企业，

通过购买知识产权，

公司与员工共同出资开展新产品研制。

目前，中心投资400万元研发的

一款家禽产品疫苗预计明年初投放市场，

将为公司带来2000多万元的增收。

高品质产品奠定品牌

图片

一直以来，

大华农为客户提供的防疫产品，

从原材料采购、生产、检测到销售

各个环节都坚持着高标准管理。

按照“人、机、料、法、环”五要素

进行全方位的生产保障。

图片

肇庆大华农实验室。

大华农还拥有一流的

动物疫病检测设备和功能实验室，

建有诊断试剂车间，能为客户提供

动物疫病防控技术的全程服务。

目前，大华农拥有四个

具备国际先进技术水平的生产基地，

每年供应禽用疫苗94亿羽份，

猪用疫苗2亿头份。

产品应用覆盖全国，

出口埃及、印尼、越南等国家和地区，

被评为“一带一路”

中国农产品出口百强企业。

图片

肇庆大华农工作人员正在进行检测工作。王振宇摄

新征程、再出发。

詹烜子表示，为了维护好“大华农”品牌，

进一步满足市场需求，

大华农今年提出新的战略目标，

全力奋战“345”：

即全力保增长、顺传��、谋上市；

通过成本驱动、市场驱动、

创新驱动、文化驱动等创新举措，

力争五年内独立上市，实现新的跨越

#zhaoqing #guangdong #china #sihui #肇庆 #四会 #大旺 #dawang

0 notes

amey-inkwood · 7 months

Text

Growing Disease Outbreaks Ascribed to Newcastle Disease Vaccine Market Growth

According to Inkwood Research, the Global Newcastle Disease Vaccine Market is expected to grow at a CAGR of 8.80% over the forecasting period of 2023-2032.

“Browse 11 Market Data Tables and 25 Figures spread over 153 Pages, along with an in-depth TOC on the Global Newcastle Disease Vaccine MarketForecast 2023-2032.”

VIEW TABLE OF CONTENT LINK - https://www.inkwoodresearch.com/reports/newcastle-disease-vaccine-market/

The growth of the global Newcastle disease vaccine market is primarily attributed to government support for animal health research and increasing awareness among farmers regarding the advantages of vaccination programs. However, stringent regulatory guidelines and insufficient diagnostic facilities pose potential challenges to market growth.

One of the infectious diseases that has a significant economic impact on the poultry business is Newcastle disease (ND). Chicken and other poultry animals' respiratory, gastrointestinal, neurological, reproductive, and immunological systems can suffer from severe tissue lesions and significant mortality rates from the highly virulent Newcastle disease virus (NDV).

REQUEST FREE SAMPLE LINK – https://inkwoodresearch.com/reports/newcastle-disease-vaccine-market/#request-free-sample

Increasing Disease Outbreaks Boosts Global Newcastle Disease Vaccine Market Growth

Poultry diseases are mostly viral and spread from one to another. Producers keep many animals together, leading to high exposure of these animals to diseases that can spread among them. Between May 2018 and May 2020, the United States Department of Agriculture (USDA) identified 476 confirmed positive premises in California infected with virulent Newcastle disease (ND), which included four commercial premises. This leads to increased demand for vaccines, which act as a measure to avoid the mass spreading of diseases and reduce or control them.

Asia-Pacific: Expected to Rise with the Highest CAGR by 2032

China has a significant market for poultry foods, and thus prevention as well as control of avian diseases is of utmost importance. Additionally, consumer demand for poultry meat has further encouraged producers to maintain livestock in the region, thus bolstering the market growth in the Asia-Pacific.

Strong competition is expected in the global market during the anticipated years. Also, some of the major enterprises operating in the global Newcastle disease vaccine market include Merck Animal Health, Zoetis, Ceva Sante Animale, etc.

Request for Customization: https://inkwoodresearch.com/request-for-custom-report/

About Inkwood Research

Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises North & South America, CEE, CIS, the Middle East, Europe, Asia, and Africa.

#Newcastlediseasevaccinemarket #Newcastlediseasevaccine #HEALTHCARE #ANIMALHEALTH #inkwoodresearch #marketresearchreports

0 notes

cmipooja · 8 months

Text

Global Poultry Diagnostics Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Molecular Diagnostic Tests

The global Poultry Diagnostics Market is estimated to be valued at US$ 536.7 million in 2023 and is expected to exhibit a CAGR of 11.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Poultry diagnostics refer to the testing and detection of various diseases and infections in poultry farms. These diagnostics play a crucial role in preventing and managing the spread of diseases amongst poultry animals, such as chickens and turkeys. The market for poultry diagnostics is driven by the increasing demand for poultry products, rising concerns about food safety, and the need for early and accurate diagnosis of diseases to prevent economic losses for farmers. Poultry diagnostics also help in improving animal welfare and overall productivity. Market Key Trends: One key trend in the global poultry diagnostics market is the increasing adoption of molecular diagnostic tests. Molecular diagnostic tests, such as PCR (polymerase chain reaction) and DNA sequencing, offer high sensitivity and specificity in detecting and identifying various infectious diseases in poultry animals. These tests enable rapid diagnosis, identification of pathogens, and monitoring disease outbreaks. For instance, Bioingentech, a key player in the poultry diagnostics market, offers molecular diagnostic kits for avian influenza virus detection. PEST Analysis: - Political: Government regulations play a significant role in the poultry industry. Stringent rules regarding food safety and disease control drive the demand for poultry diagnostics. - Economic: The demand for poultry products is increasing worldwide due to population growth and rising disposable incomes. This fuels the need for efficient disease management through diagnostics. - Social: Consumer awareness about food safety and the importance of disease-free poultry products is growing, leading to the adoption of poultry diagnostics. - Technological: Advancements in diagnostic technologies, such as point-of-care testing and real-time PCR, are revolutionizing the poultry diagnostics market. These technologies offer faster and more accurate results. Key Takeaways: Paragraph 1: The Global Poultry Diagnostics Market Demand is expected to witness high growth, exhibiting a CAGR of 11.4% over the forecast period, due to increasing adoption of molecular diagnostic tests. These tests provide rapid and accurate detection of infectious diseases, ensuring timely disease management and prevention of economic losses for farmers. Paragraph 2: The North America region is expected to dominate the global poultry diagnostics market, primarily driven by the presence of major market players, well-established poultry industry, and strict regulations on food safety. Asia Pacific is expected to be the fastest-growing region due to the increasing demand for poultry products and the need for efficient disease management in densely populated countries like China and India. Paragraph 3: Key players operating in the global poultry diagnostics market include Zoetis, Thermo Fisher Scientific Inc., Baltivet, Bioingentech, Devex, BioChek, QIAGEN, Bioneer Corporation, Megacor Diagnostik GmbH, Merck & Co., Inc., IdentiGEN, Abaxis, BIOMERIEUX, Transasia Bio-Medicals, Boehringer Ingelheim International GmbH, EW Group Ltd., and Hygiena, LLC. These players focus on product innovation, strategic collaborations, and acquisitions to gain a competitive edge in the market.

#Poultry Diagnostics Market #Poultry Diagnostics Market Insights #Poultry Diagnostics Market Demand #Poultry Diagnostics Market Forecast #Poultry Diagnostics Market Analysis #Poultry Diagnostics Market Values #diseases #poultry farmers #healthy poultry products #Rapid diagnostic tests

0 notes

healthcaremarketfmi · 9 months

Text

Veterinary Molecular Diagnostics Market Growth Analysis, Outlook by – Trends, Opportunities and Forecast 2023-2033

In 2022, the market for veterinary molecular diagnostics is projected to be worth US$182.1 million. The overall demand for veterinary molecular diagnostics is anticipated to increase at a CAGR of 6.84% between 2022 and 2032, reaching a total of about US$ 352.8 Million by 2032 due to the adoption of multiple testing panels and the growing consolidation in the veterinary diagnostics industry.

According to the latest market report published by Future Market Insights, titled ‘Veterinary Molecular Diagnostics Market: Global Industry Analysis (2013-2021) and Forecast (2022-2026)’, the global veterinary molecular diagnostics market is expected to expand at a CAGR of 7.6% during the forecast period 2022–2028.

The market is segmented based on product type, disease type, species type, end-user, and region. On the basis of product type, the market has been segmented into four segments such as PCR kits, INAAT kits, microarray kits, DNA sequencing kits.

PCR kits segment is expected to be the fastest-growing segment over the forecast period, registering a significant CAGR of 7.8% in terms of revenue, over the forecast period. The increasing demand for advanced veterinary molecular diagnostic kits, such as RT-PCR kits, DNA sequencing kits, and microarray-based diagnostic kits owing to the growing number of diagnostic procedures in livestock and companion animals worldwide is expected to boost the growth of the veterinary molecular diagnostics market over the forecast period.

The PCR kits segment dominates the market with a market value of US$ 63.4 Mn in 2017. Also, the segment is expected to maintain its dominance over the forecast period with a market value of US$ 124.0 by 2026 end and expands at a significant CAGR.

On the basis of disease type, the market has been segmented into Anaplasma spp., Ehrlichia spp., New Castle Disease, Influenza, Porcine Reproductive & Respiratory Syndrome (PRRS), and others.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6742

Based on species type, the market has been segmented into livestock animals including Aquatic, Bovine, Porcine, Ovine, Poultry, and Equine.

On the basis of end-user, the market has been segmented into veterinary hospitals, clinical laboratories, and veterinary research institutes.

On the basis of region, the market has been segmented into North America, Latin America, Europe, the Asia Pacific Excluding China (APEC), China, and the Middle East and Africa (MEA).

Increasing set up of new production facilities by the key manufacturers in growing economies coupled with increasing adoption of molecular diagnostic techniques in animals is anticipated to boost the production for molecular diagnostic kits and drives the growth of the veterinary molecular diagnostics market over a forecast period.

0 notes

desaletushki · 10 months

Text

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report, 2030

The global CRISPR and Cas genes marketsize is expected to reach USD 9.61 billion by 2030, growing at a CAGR of 17.15% from 2023 to 2030, according to a new report by Grand View Research, Inc. The use of CRISPR-Cas systems in diagnostics and the assessment of evolutionary analysis in prokaryotes has significantly increased, owing to the developments in the field of genome editing. The application of this technology enables easy and cost-efficient editing of genes. Genome editing has made a significant advancement in biomedical research, with the present trend of cutting-edge techniques paving the way for the future treatment of different genetic and non-genetic disorders.

The development and implementation of more effective ways for gene targeting and the generation of gene-edited avian species have been facilitated by the availability of the CRISPR/Cas9-mediated gene and genome editing technology. According to an article published on Frontiers in February 2021, CRISPR/Cas9 has become a robust and important tool for gene editing in the poultry industry. Potential applications in several fields would further boost the demand for this technology. The COVID-19 outbreak shifted the researcher’s emphasis to the development of COVID-19 molecular diagnostic tools based on this technology. For instance, in March 2021, Nanyang Technological University researchers in Singapore created a COVID-19 test based on CRISPR that provides results in 30 minutes.

Request a free sample copy or view the report summary: https://www.grandviewresearch.com/industry-analysis/crispr-associated-cas-genes-market

Even after the virus has mutated, this test still discovers it. This would further encourage the other key players to leverage this technique, thereby driving the industry's growth. This technology is increasingly being used for several medical and other applications. Competition over patents for such a gene-editing technology is expected to grow, as more academic institutions and biotech companies attempt to develop new commercial applications of this technology. In addition, there is a lot of potential for this technique to advance with the use of machine learning technologies. For instance, in August 2022, Synthego launched engineered cell libraries, a cutting-edge service that expands access to CRISPR by giving arrayed CRISPR-edited cells for use directly in functional screening experiments.

It has potential applications in disease research. Key players offer tools and solutions for each step of the gene editing workflow. Integrating several tools, services, and improved processes makes it possible to complete research experiments rapidly and with little effort. Moreover, key players have raised significant funding to support the R&D of the CRISPR & Cas9 gene-editing approach. For instance, in April 2021, Vertex Pharmaceuticals collaborated with CRISPR Therapeutics to develop and manufacture a new CRISPR/Cas9-based gene editing therapy called CTX001, a potential therapeutic option for transfusion-dependent beta-thalassemia and Sickle Cell Disease (SCD). In January 2020, Mammoth Biosciences raised USD 45 million to develop next-gen CRISPR products for therapeutics & diagnostics purposes. This would further be used to develop the company’s CRISPR genes-driven diagnostics portfolio.

CRISPR And Cas Genes Market Report Highlights

By product and services, the product segment dominated the industry in 2022 and accounted for the highest share of 78.86%

The biomedical segment dominated the industry in 2022. Extensive research and a significant rise in the number of research studies utilizing the advanced technique for genome editing have contributed to the segment growth

The biotechnology and pharmaceutical companies dominated the market in 2022, accounting for 49.68% of overall revenue share. Key players are adopting this technology to produce biological models for human diseases and further accelerate new therapeutic target identification

North America dominated the market and accounted for the highest revenue share of 38.37% in 2022 owing to the presence of several pharmaceutical giants, increased research funding, a high number of research approvals, and the need for novel therapeutics

CRISPR And Cas Genes Market Segmentation

Grand View Research has segmented the global CRISPR and Cas genes market based on product & service, application, end-use, and region:

CRISPR And Cas Genes Product & Service Outlook (Revenue, USD Million, 2018 - 2030)

By Product

Kits & Enzymes

Vector-based Cas

DNA-free Cas

Libraries

Design Tool

Antibodies

Others

By Service

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA Synthesis

CRISPR And Cas Genes Application Outlook (Revenue, USD Million, 2018 - 2030)

Biomedical

Genome Engineering

Disease Model Studies

Functional Genomics

Epigenetics

Others

Agricultural

CRISPR And Cas Genes End-use Outlook (Revenue, USD Million, 2018 - 2030)

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

Regional Insights

North America dominated the market and accounted for the highest revenue share of 38.37% in 2022. The growing biopharmaceutical R&D as well as the involvement of several pharmaceutical corporations in the creation of novel therapeutics has contributed towards the region’s growth. For instance, in May 2020, Merck KGaA received U.S. approval. For two of its CRISPR Cas9-driven gene-editing patents.

Asia Pacific region is anticipated to witness the fastest CAGR of 17.53% during the forecast period. The increasing government investment in R&D to develop novel treatments is aiding in market expansion Japan and China is anticipated to support the region’s growth. For instance, in March 2021, Japanese biotech company Setsuro Tech received a patent for CRISPR-Cas9 technology from Dublin-based ERS Genomics. The company is creating animal and cell models using these advanced technologies. Such initiatives are predicted to enhance CRISPR technology adoption in the region, further contributing towards revenue generation.

List of Key Players of CRISPR And Cas Genes Market

AstraZeneca plc

Addgene

Caribou Biosciences, Inc.

Cellectis, CRISPR Therapeutics

Editas Medicine, Inc.

eGenesis

Hoffmann-La Roche Ltd.

Horizon Discovery Group plc

GenScript

Danaher Corp.

Intellia Therapeutics, Inc.

Lonza

Merck KGaA

Intellia Therapeutics, Inc.

Takara Bio Inc.

Thermo Fisher Scientific, Inc.

Synthego

Mammoth Biosciences

Inscripta, Inc.

Cibus

Beam Therapeutics

PLANTeDIT

Vertex Pharmaceuticals Inc.

Hera BioLabs

OriGene Technologies, Inc.

Recombinetics, Inc.

Authoritative Research: https://www.grandviewresearch.com/industry-analysis/crispr-associated-cas-genes-market

#CRISPR And Cas Genes Market #CRISPR And Cas Genes Market Size #CRISPR And Cas Genes Market Share #CRISPR And Cas Genes Market Growth

0 notes